Gideon Lasco et al. provides a thorough analysis on the state of harm reduction in 2020, from global-spanning diseases to regionally based health and human rights concerns.
The Canadian Drug Policy Coalition provides an overview of drug-related challenges in Canada and pathways toward sustainable solutions anchored in public health and harm reduction.
AFEW's survey sheds light on the impact of the COVID-19 pandemic and associated restrictions on civil society in terms of their staff's health, operations and sustainability.
In the current US opioid crisis, where a third of all those addicted to heroin pass through its prisons each year, the care of incarcerated people who use opioids needs to be improved.
This brief examines approaches state policymakers can take to make naloxone widely available to people at risk of experiencing or witnessing an overdose.
Steve Rolles et al. argue the regulation of illicit substances provides an effective avenue to manage the risks of drugs and drug markets, both for those who use them and for wider society.
INPUD reveals how the HIV epidemic in Kyrgyzstan is dangerously outpacing the country's response in terms of government aid and community-led initiatives to combat the crisis.
Aidsfonds warns the dearth of funding for key populations in the HIV response (only 2% of the total) jeopardises international agreements to end AIDS by 2030.
Shirley-Beavan et al. demonstrates how women and gender non-conforming people who use drugs face unique barriers to proper health care and receiving access to harm reduction services.
Clean Start provides formerly-incarcerated women with avenues for healing, education and employment, breaking cycles of criminalisation and vulnerability.
Bonn et al. urge for a continuation of effective responses implemented during the pandemic, including emergency safe-supply prescribing and housing provision, and further efforts to address the harms of criminalisation and prohibition.
The Centre on Drug Policy Evaluation established that much work remains to achieve a diverse, competitive and legal cannabis industry in Canada, in ordert to ensure that historically over criminalised racialized groups are not excluded.
The Colombian Observatory of Organized Crime draws on lessons from the production of opium and cannabis for medical purposes to suggest pathways toward viable legal markets for coca products.
The Robert Carr Fund presents its 2019 annual report discussing the achievements in supporting the health, social inclusion and well-being of inadequately served populations.
Eggins et al. found that there is limited high-quality scientific evidence that can be used to examine the impact of the law-enforcement mechanisms of supplier arrest and seizure on a range of drug-related outcomes.
Using evidence from the HIV response, UNAIDS shines a light on forms of stigma encountered in six aspects of national; including education, the workplace, human rights, and emergency services.
The World Bank Group highlights the importance of scaling up treatment and prevention, including harm reduction methods and the benefits of sophisticated modelling.
The legalisation of the drug market as a way to undermine the power of organised crime groups and reducing the risk of vulnerable people by diminishing the opportunity and profit motive for human exploitation.
